Literature DB >> 31723058

Hemagglutinin head-specific responses dominate over stem-specific responses following prime boost with mismatched vaccines.

Sinthujan Jegaskanda1,2, Sarah F Andrews3, Adam K Wheatley2,3, Jonathan W Yewdell4, Adrian B McDermott3, Kanta Subbarao1.   

Abstract

Broadly neutralizing Abs targeting the HA stem can provide broad protection against different influenza subtypes, raising the question of how best to elicit such Abs. We have previously demonstrated that vaccination with pandemic live-attenuated influenza vaccine (pLAIV) establishes immune memory for HA head-specific Abs. Here, we determine the extent to which matched versus mismatched LAIV-inactivated subunit vaccine (IIV) prime-boost vaccination elicits stem-specific memory B cells and Abs. We vaccinated African green monkeys with H5N1 pLAIV-pIIV or H5N1 pLAIV followed by seasonal IIV (sIIV) or with H5N1 pLAIV alone and measured Abs and HA-specific B cell responses. While we observed an increase in stem-specific memory B cells, head-specific memory B cell responses were substantially higher than stem-specific responses and were dominant even following boost with mismatched IIV. Neutralizing Abs against heterologous influenza viruses were undetectable. Head-specific B cells from draining lymph nodes exhibited germinal center markers, while stem-specific B cells found in the spleen and peripheral blood did not. Thus, although mismatched prime-boost generated a pool of stem-specific memory B cells, head-specific B cells and serum Abs substantially dominated the immune response. These findings have implications for including full-length native HA in prime-boost strategies intended to induce stem-specific Abs for universal influenza vaccination.

Entities:  

Keywords:  Infectious disease; Influenza; Vaccines

Year:  2019        PMID: 31723058      PMCID: PMC6948858          DOI: 10.1172/jci.insight.129035

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  43 in total

1.  CXCL13 is a plasma biomarker of germinal center activity.

Authors:  Colin Havenar-Daughton; Madelene Lindqvist; Antje Heit; Jennifer E Wu; Samantha M Reiss; Kayla Kendric; Simon Bélanger; Sudhir Pai Kasturi; Elise Landais; Rama S Akondy; Helen M McGuire; Marcella Bothwell; Parsia A Vagefi; Eileen Scully; Georgia D Tomaras; Mark M Davis; Pascal Poignard; Rafi Ahmed; Bruce D Walker; Bali Pulendran; M Juliana McElrath; Daniel E Kaufmann; Shane Crotty
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-23       Impact factor: 11.205

2.  Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages.

Authors:  James R R Whittle; Adam K Wheatley; Lan Wu; Daniel Lingwood; Masaru Kanekiyo; Steven S Ma; Sandeep R Narpala; Hadi M Yassine; Gregory M Frank; Jonathan W Yewdell; Julie E Ledgerwood; Chih-Jen Wei; Adrian B McDermott; Barney S Graham; Richard A Koup; Gary J Nabel
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

3.  Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.

Authors:  Davide Corti; Amorsolo L Suguitan; Debora Pinna; Chiara Silacci; Blanca M Fernandez-Rodriguez; Fabrizia Vanzetta; Celia Santos; Catherine J Luke; Fernando J Torres-Velez; Nigel J Temperton; Robin A Weiss; Federica Sallusto; Kanta Subbarao; Antonio Lanzavecchia
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

4.  A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.

Authors:  Ji-Young Min; Leatrice Vogel; Yumiko Matsuoka; Bin Lu; David Swayne; Hong Jin; George Kemble; Kanta Subbarao
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

5.  Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes.

Authors:  Sinthujan Jegaskanda; Rosemarie D Mason; Sarah F Andrews; Adam K Wheatley; Ruijun Zhang; Glennys V Reynoso; David R Ambrozak; Celia P Santos; Catherine J Luke; Yumiko Matsuoka; Jason M Brenchley; Heather D Hickman; Kawsar R Talaat; Sallie R Permar; Hua-Xin Liao; Jonathan W Yewdell; Richard A Koup; Mario Roederer; Adrian B McDermott; Kanta Subbarao
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

6.  African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.

Authors:  Yumiko Matsuoka; Amorsolo Suguitan; Marlene Orandle; Myeisha Paskel; Kobporn Boonnak; Donald J Gardner; Friederike Feldmann; Heinz Feldmann; Michael Marino; Hong Jin; George Kemble; Kanta Subbarao
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

7.  A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.

Authors:  Ruth A Karron; Karen Callahan; Catherine Luke; Bhagvanji Thumar; Josephine McAuliffe; Elizabeth Schappell; Tomy Joseph; Kathleen Coelingh; Hong Jin; George Kemble; Brian R Murphy; Kanta Subbarao
Journal:  J Infect Dis       Date:  2009-03-01       Impact factor: 5.226

8.  Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.

Authors:  Ruth A Karron; Kawsar Talaat; Catherine Luke; Karen Callahan; Bhagvanji Thumar; Susan Dilorenzo; Josephine McAuliffe; Elizabeth Schappell; Amorsolo Suguitan; Kimberly Mills; Grace Chen; Elaine Lamirande; Kathleen Coelingh; Hong Jin; Brian R Murphy; George Kemble; Kanta Subbarao
Journal:  Vaccine       Date:  2009-06-21       Impact factor: 3.641

9.  Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.

Authors:  Greg A Kirchenbaum; Donald M Carter; Ted M Ross
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

10.  Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.

Authors:  Jens Wrammert; Dimitrios Koutsonanos; Gui-Mei Li; Srilatha Edupuganti; Jianhua Sui; Michael Morrissey; Megan McCausland; Ioanna Skountzou; Mady Hornig; W Ian Lipkin; Aneesh Mehta; Behzad Razavi; Carlos Del Rio; Nai-Ying Zheng; Jane-Hwei Lee; Min Huang; Zahida Ali; Kaval Kaur; Sarah Andrews; Rama Rao Amara; Youliang Wang; Suman Ranjan Das; Christopher David O'Donnell; Jon W Yewdell; Kanta Subbarao; Wayne A Marasco; Mark J Mulligan; Richard Compans; Rafi Ahmed; Patrick C Wilson
Journal:  J Exp Med       Date:  2011-01-10       Impact factor: 14.307

View more
  4 in total

Review 1.  Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses.

Authors:  Lucas J Kerstetter; Stephen Buckley; Carly M Bliss; Lynda Coughlan
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

Review 2.  Protein engineering strategies for rational immunogen design.

Authors:  Timothy M Caradonna; Aaron G Schmidt
Journal:  NPJ Vaccines       Date:  2021-12-17       Impact factor: 7.344

3.  TLR agonists induce sustained IgG to hemagglutinin stem and modulate T cells following newborn vaccination.

Authors:  Elene A Clemens; Beth C Holbrook; Brendan McNeilly; Masaru Kanekiyo; Barney S Graham; Martha A Alexander-Miller
Journal:  NPJ Vaccines       Date:  2022-08-29       Impact factor: 9.399

4.  An R848-Conjugated Influenza Virus Vaccine Elicits Robust Immunoglobulin G to Hemagglutinin Stem in a Newborn Nonhuman Primate Model.

Authors:  Elene A Clemens; Beth C Holbrook; Masaru Kanekiyo; Jonathan W Yewdell; Barney S Graham; Martha A Alexander-Miller
Journal:  J Infect Dis       Date:  2021-07-15       Impact factor: 5.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.